ARCHIVES

In Brief: Jane Henney, Former NCI Deputy Director, Named FDA Deputy Commissioner For Operations

This article is from The Cancer Letter archive.

Vol. 17 No. 44 | November 15, 1991

Download PDF Visit The Full Archive

Related Articles

ASCO Recommends Aromatase Inhibitors As Adjuvant For Some Breast Cancer

July 30, 2010

Some NCI Responses To CCOP Letters Of Intent Missing; NCAB Debates Pediatric Issues

October 8, 1982

Three Organizations Publish Guideline For Biomarker Testing for Targeted Therapies

April 26, 2013

Kessler Says FDA Working To Expedite Secondary Approvals

January 31, 1992

Thompson Tours Brown’s Brain Science Center.

March 16, 2001

Capitol Hill: Sen. Harkin Introduces NIH Funding Bill That Boosts Budget to $46.2 Billion by 2021

July 25, 2014